SABBY MANAGEMENT, LLC

Est. AUM

$45.07B

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	SPDR S&P 500 ETFPUT	ETF	$29.07B	447	64.50%	DFND
2	ISHARES TRPUT	ETF	$7.44B	300	16.51%	DFND
3	SPDR S&P 500 ETF	ETF	$1.78B	2734	3.94%	DFND
4	GEVO INCPUT	COM	$1.43B	5252	3.18%	DFND
5	ABIVAX SACALL	ADS	$857.4M	77	1.90%	DFND
6	ALPHATON CAPITAL CORP	SHS	$654.8M	2072103	1.45%	DFND
7	BRIACELL THERAPEUTICS CORP	*W	$392.1M	380686	0.87%	DFND
8	SENESTECH INC	COM	$358.4M	218533	0.80%	DFND
9	BIG TREE CLOUD HLDGS LTD	CL A	$337.1M	137611	0.75%	DFND
10	ZEVRA THERAPEUTICS INCPUT	COM	$316.9M	340	0.70%	DFND
11	BRIACELL THERAPEUTICS CORP	COM	$309.7M	73915	0.69%	DFND
12	SIDUS SPACE INCPUT	COM	$243.4M	1049	0.54%	DFND
13	TOKEN CAT LTD	ADS	$241.7M	23239	0.54%	DFND
14	POP CULTURE GROUP CO LTD	SHS	$201.1M	664449	0.45%	DFND
15	MOLECULIN BIOTECH INC	COM	$171.8M	75021	0.38%	DFND
16	BIODEXA PHARMACEUTICALS PLC	ADS	$159.1M	257472	0.35%	DFND
17	ARCADIA BIOSCIENCES INC	COM	$158.1M	114554	0.35%	DFND
18	TRX GOLD CORP	COM	$150.0M	100000	0.33%	DFND
19	INMED PHARMACEUTICALS INC	COM	$142.0M	220260	0.32%	DFND
20	CAN FITE BIOFARMA LTD	ADR	$131.9M	42559	0.29%	DFND
21	CHINA SXT PHARMACEUTICALS INC	CL A	$131.3M	78170	0.29%	DFND
22	REVELATION BIOSCIENCES INC	COM	$119.3M	99432	0.26%	DFND
23	CALIDI BIOTHERAPEUTICS INC	COM	$103.9M	434903	0.23%	DFND
24	BLUEJAY DIAGNOSTICS INC	COM	$52.9M	28726	0.12%	DFND
25	LYRA THERAPEUTICS INC	COM	$51.1M	104059	0.11%	DFND
26	TEMPEST THERAPEUTICS INC	COM	$29.3M	17856	0.06%	DFND
27	BRIACELL THERAPEUTICS CORP	*W	$28.9M	206753	0.06%	DFND
28	BNB PLUS CORP	COM	$8.7M	13541	0.02%	DFND

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.